A BAYESIAN GRAPHICAL MODELING APPROACH TO MICRORNA REGULATORY NETWORK INFERENCE.
Francesco C Stingo1, Yian A Chen, Marina Vannucci
1Department of Statistics, University of Florence, 50134 Florence, Italy.
The Annals of Applied Statistics
|August 16, 2013
Summary
This study introduces a Bayesian graphical model to map microRNA (miRNA) regulatory networks by integrating gene expression data with sequence information. The novel approach identifies potential miRNA targets, advancing our understanding of gene regulation.
Area of Science:
- Genomics
- Bioinformatics
- Molecular Biology
Background:
- MicroRNAs (miRNAs) regulate approximately 30% of human genes.
- Current miRNA target prediction relies heavily on sequence and structure data.
- A comprehensive understanding of miRNA regulatory networks is crucial for biological insights.
Purpose of the Study:
- To develop a Bayesian graphical modeling approach for inferring miRNA regulatory networks.
- To integrate diverse data sources, including miRNA and mRNA expression levels and sequence/structure information.
- To identify novel miRNA-target gene interactions.
Main Methods:
- Utilized a directed graphical model tailored to biological data.
- Employed stochastic search methods and Markov Chain Monte Carlo (MCMC) for network inference.
- Incorporated a time-dependent coefficients model.
- Integrated miRNA and mRNA expression data with sequence/structure priors.
Main Results:
- Successfully inferred a miRNA regulatory network by integrating multiple data types.
- Identified plausible miRNA-target gene pairs from experimental data on hyperthermia-induced neural tube defects.
- Demonstrated the model's capability to handle large, complex biological datasets.
Conclusions:
- The proposed Bayesian graphical modeling approach effectively infers miRNA regulatory networks.
- The method offers a robust framework for integrating diverse biological data.
- The identified miRNA-target interactions warrant further experimental validation and hold potential for future research.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

